Deutsche Bank Aktiengesellschaft »

Rayzebio shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Rayzebio shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Rayzebio

Tip: Access up to 7 years of quarterly data

All positions including Rayzebio held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rayzebio by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $619k 10k 62.17

More positions owned by Deutsche Bank Aktiengesellschaft

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Adobe Systems Incorporated (ADBE)

View all positions for Deutsche Bank Aktiengesellschaft

Top funds holding Rayzebio

Viking Global Investors
venBio Partners
VR Adviser
Wellington Management Company
OrbiMed Advisors
Redmile Group
Samsara BioCapital
Fairmount Funds Management
Cormorant Asset Management
Hillhouse Capital Advisors
Deerfield Management Company
Alliancebernstein
Laurion Capital Management
Soleus Capital Management
Perceptive Advisors

View all funds holding Rayzebio